Similar articles

• Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study.

  Tougeron D, Mouillet G, Trouilloud I, Lecomte T, Coriat R, Aparicio T, Des Guetz G, Lécaille C, Artru P, Sickersen G, Cauchin E, Sefrioui D, Boussaha T, Ferru A, Matysiak-Budnik T, Silvain C, Karayan-Tapon L, Pagès JC, Vernerey D, Bonnetain F, Michel P, Taïeb J, Zaanan A. Tougeron D, et al. J Natl Cancer Inst. 2016 Feb 1;108(7). doi: 10.1093/jnci/djv438. Print 2016 Jul. J Natl Cancer Inst. 2016. PMID: 26839356
• [Occurrence of small cell lung cancer after long-term benefit from envafolimab for advanced MSI-H/dMMR colon cancer].

  Liu C, Meng FL, Guan SS, Zhong DS. Liu C, et al. Zhonghua Zhong Liu Za Zhi. 2023 Nov 23;45(11):988-990. doi: 10.3760/cma.j.cn112152-20220827-00582. Zhonghua Zhong Liu Za Zhi. 2023. PMID: 37968086 Chinese. No abstract available.
• Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.

  Kim ST, Lee J, Park SH, Park JO, Lim HY, Kang WK, Kim JY, Kim YH, Chang DK, Rhee PL, Kim DS, Yun H, Cho YB, Kim HC, Yun SH, Lee WY, Chun HK, Park YS. Kim ST, et al. Cancer Chemother Pharmacol. 2010 Sep;66(4):659-67. doi: 10.1007/s00280-009-1206-3. Epub 2009 Dec 24. Cancer Chemother Pharmacol. 2010. PMID: 20033812
• Microsatellite instability in the management of colorectal cancer.

  Pino MS, Chung DC. Pino MS, et al. Expert Rev Gastroenterol Hepatol. 2011 Jun;5(3):385-99. doi: 10.1586/egh.11.25. Expert Rev Gastroenterol Hepatol. 2011. PMID: 21651356 Review.
• Immunotherapy and patients treated for cancer with microsatellite instability.

  Colle R, Cohen R, Cochereau D, Duval A, Lascols O, Lopez-Trabada D, Afchain P, Trouilloud I, Parc Y, Lefevre JH, Fléjou JF, Svrcek M, André T. Colle R, et al. Bull Cancer. 2017 Jan;104(1):42-51. doi: 10.1016/j.bulcan.2016.11.006. Epub 2016 Dec 13. Bull Cancer. 2017. PMID: 27979364 Review.